Zobrazeno 1 - 10
of 954
pro vyhledávání: '"LJ Martinez"'
Autor:
Arnaut, Nicoleta1 (AUTHOR) arnaut.nicoleta99@gmail.com, Ciurea, Cristina Nicoleta2,3 (AUTHOR), Cighir, Anca2,3 (AUTHOR)
Publikováno v:
Acta Marisiensis. Seria Medica. Sep2024, Vol. 70 Issue 3, p105-111. 7p.
Publikováno v:
Scientific Reports. 8/23/2024, Vol. 14 Issue 1, p1-12. 12p.
Autor:
Wang, Yu1,2 (AUTHOR), Wei, Wenjun1 (AUTHOR), Guo, Heming2 (AUTHOR), Wang, Dengmin1 (AUTHOR), Wei, Xueli2 (AUTHOR), Zhang, Chunlan2 (AUTHOR), Zhang, Xiaoyan2 (AUTHOR) zhxyan888@sina.com, Huang, Yun2 (AUTHOR)
Publikováno v:
Journal of Diabetes Investigation. Aug2024, Vol. 15 Issue 8, p1115-1128. 14p.
Autor:
R Morón Romero, LJ Martinez, CL Dávila Fajardo, X Diaz Villamarin, M Valle Corpas, D Blanquez Martinez, MJ Soto Pino, J Cabeza Barrera, E Raya Alvarez, Mdc Gonzalez Medina
Publikováno v:
European Journal of Hospital Pharmacy. 23:A142.1-A142
Background Tocilizumab (TCZ) is a humanised monoclonal antibody inhibitor of interleukin 6 receptor, indicated in combination with methotrexate in the treatment of rheumatoid arthritis (RA) in patients with inadequate response or intolerance to prior
Autor:
P Toledo Frías, F Burillo Gómez, A Bautista Pavés, C Correa Vilches, JG Sanchez Ramos, X Diaz Villamarin, S Martinez Huertas, LJ Martinez Gonzalez, J Cabeza Barrera, CL Dávila Fajardo
Publikováno v:
European Journal of Hospital Pharmacy. 23:A188.1-A188
Background Clopidogrel provides a reduction in cardiovascular events in acute coronary syndrome (ACS) patients, particularly for those who have undergone percutaneous coronary intervention (PCI). The cardiovascular response has been associated with s
Autor:
Lin, Jia-Hung1 (AUTHOR), Lin, Chi-Huei1 (AUTHOR), Kuo, Yi-Wei1 (AUTHOR), Liao, Chorng-An2 (AUTHOR), Chen, Jui-Fen3 (AUTHOR), Tsai, Shin-Yu3 (AUTHOR), Li, Ching-Min3 (AUTHOR), Hsu, Yu-Chieh3 (AUTHOR), Huang, Yen-Yu3 (AUTHOR), Hsia, Ko-Chiang3 (AUTHOR), Yeh, Yao-Tsung2,4 (AUTHOR) glycosamine@yahoo.com.tw, Ho, Hsieh-Hsun1,3 (AUTHOR) glycosamine@yahoo.com.tw
Publikováno v:
PLoS ONE. 7/24/2024, Vol. 19 Issue 7, p1-22. 22p.
Autor:
Liang, Yuxuan1,2 (AUTHOR), Zhang, Qingrong1,2 (AUTHOR), Yu, Jing3,4 (AUTHOR), Hu, Wenyan1,2 (AUTHOR), Xu, Sihua1,2 (AUTHOR), Xiao, Yiyuan1,2 (AUTHOR), Ding, Hui5 (AUTHOR) 6432206@163.com, Zhou, Jiaming3,4 (AUTHOR) zhoujiam@mail.sysu.edu.cn, Chen, Haitao1,2 (AUTHOR) chenht56@mail.sysu.edu.cn
Publikováno v:
BMC Microbiology. 7/3/2024, Vol. 24 Issue 1, p1-11. 11p.
Autor:
Talebi, Sepide1,2 (AUTHOR), Mehrabani, Sanaz3 (AUTHOR), Ghoreishy, Seyed Mojtaba4,5 (AUTHOR), Wong, Alexei6 (AUTHOR), Moghaddam, Aliasghar7 (AUTHOR), Feyli, Peyman Rahimi7 (AUTHOR), Amirian, Parsa8 (AUTHOR), Zarpoosh, Mahsa8 (AUTHOR), Kermani, Mohammad Ali Hojjati9 (AUTHOR), Moradi, Sajjad10 (AUTHOR) s.moradi@mrgums.ac.ir
Publikováno v:
BMC Pregnancy & Childbirth. 5/15/2024, Vol. 24 Issue 1, p1-17. 17p.
Autor:
Zesheng Lin1, Wenjing Luo2, Kaijun Zhang3 gdsrmyyzkj@163.com, Shixue Dai3,4 shixuedai@hotmail.com
Publikováno v:
Gut & Liver. May2024, Vol. 18 Issue 3, p370-390. 21p.
Autor:
JG Sanchez Ramos, X Diaz Villamarin, LJ Martinez Gonzalez, Mdc Marin, S Martinez Huertas, Francisco V. Fernández, J Cabeza Barrera, CL Dávila Fajardo
Publikováno v:
European Journal of Hospital Pharmacy. 22:A132.1-A132
Background Clopidogrel is metabolised by CYP2C19 to the active metabolite responsible for the inhibition of platelet aggregation. The P-glycoprotein encoded by the ABCB1 gene is key in drug absorption. The effects differ according to genotype ABCB1 a